PPT-The Biopharmaceutical Industry’s Challenge in Drug Pricing

Author : aaron | Published Date : 2018-12-08

John L LaMattina CURE Yale Biohaven April 25 2017 Drug Pricing Now A National Discussion Turing Pharmaceuticals Martin Shkreli raised the price of Daraprim for

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "The Biopharmaceutical Industry’s Chall..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

The Biopharmaceutical Industry’s Challenge in Drug Pricing: Transcript

John L LaMattina CURE Yale Biohaven April 25 2017 Drug Pricing Now A National Discussion Turing Pharmaceuticals Martin Shkreli raised the price of Daraprim for toxoplasmosis from 1350 to 750 tablet. March 27th 2014, University of Zurich . Fabienne Heimgartner, Interpharma. What. . it. . needs. . for. . one. . drug. CHF . investment. working. . hours. . experiments. scientists. drug. 1 000 000 000. Timothy F Christian, MD, MPA. Characteristics of Big . Pharma. One of OECD largest industries. In US: sales = $380 Billion. R&D costs. =$40 Billion. Single drug to market=$1-4 Billion. The fixed cost in R&D and IP is high. Sarah K. Emond, MPP. August 9, 2017. Working Group Charge (draft). This work group will develop for recommendation to the Health Care Cabinet, a proposal to create an actionable plan to align payer contracting with pharmaceutical manufacturers, PBMs, providers and pharmacies that . Luka Jankovic, Alexa Davis, Laila Judeh Spring 2015 AEM 4160: Strategic Pricing. Executive Summary. By The Strategic . Pricers. :. Davis Austin. Ty . Bostain. Nick . Baccile. Daniel . Weisen. . Game Plan. Introduction. Why did we choose the cruise line industry?. Personal Interests and experience in the industry.. By The Strategic . Pricers. :. Davis Austin. Ty . Bostain. Nick . Baccile. Daniel . Weisen. . Game Plan. Introduction. Why did we choose the cruise line industry?. Personal Interests and experience in the industry.. W. Neil Palmer. President & Principal Consultant. Neil.Palmer@pdci.ca . The Canadian Institute. Drug Pricing & Reimbursement in Canada. Toronto – June 4 & 5, 2013. 1. June 2013. Outline. Luka Jankovic, Alexa Davis, Laila Judeh Spring 2015 AEM 4160: Strategic Pricing. Executive Summary. By The Strategic . Pricers. :. Davis Austin. Ty . Bostain. Nick . Baccile. Daniel . Weisen. . Game Plan. Introduction. Why did we choose the cruise line industry?. Personal Interests and experience in the industry.. By The Strategic . Pricers. :. Davis Austin. Ty . Bostain. Nick . Baccile. Daniel . Weisen. . Game Plan. Introduction. Why did we choose the cruise line industry?. Personal Interests and experience in the industry.. Luka Jankovic, Alexa Davis, Laila Judeh Spring 2015 AEM 4160: Strategic Pricing. Executive Summary. Philip J. Schneider MS, FASHP, FASPEN, FFIP. Professor and Associate Dean. University of Arizona College of Pharmacy. Phoenix Biomedical Campus. Yes!. The business community. The political arena. Payers. Kelly Hansen. Chelsea . Karpenko. Katie . Kenealy-Bredice. Stephanie Pratt. Table of contents. Introduction. Industry Structure. Background. Competition. Organization. Major Companies. Pricing Strategies. 21 Jan 2016. Symposium: New Frontiers in Antibacterial Resistance Research. John H. Rex, MD. 2016-01-21 AMR Research Frontiers - Challenge of clinical studies. 1. Senior VP and Chief Strategy Officer, AstraZeneca Antibiotics Business Unit; Non-Executive Director, F2G Ltd. and .

Download Document

Here is the link to download the presentation.
"The Biopharmaceutical Industry’s Challenge in Drug Pricing"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.